Forte Biosciences (FBRX) Revenue (2017 - 2019)
Forte Biosciences (FBRX) posted quarterly Revenue of $9000.0 for Q4 2019, little changed year-over-year from $9000.0 in Q4 2018, and little changed quarter-over-quarter from $9000.0 in Q3 2019.
Powered by 
Analysis
Forte Biosciences (FBRX) Revenue (2017 - 2019) Analysis & Trends
Forte Biosciences (FBRX) has reported Revenue for 3 consecutive years, with $9000.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Revenue changed 0.0% year-over-year to $9000.0; the TTM figure through Dec 2019 stood at $36000.0 (down 99.8% YoY), while the FY2019 annual figure was $36000.0, down 99.8% from the prior year.
- Revenue steadied at $9000.0 in Q4 2019 per FBRX's latest filing, from $9000.0 in the prior quarter.
- Across five years, Revenue topped out at $18.0 million in Q3 2018 and bottomed at $9000.0 in Q1 2018.
- Historically, Revenue has averaged $1.6 million across 3 years, with a median of $9000.0 in 2018.
- Annual changes were most pronounced in 2018 — Revenue jumped 179990.0% — and 2019, when it slumped 99.95%.
- Forte Biosciences' Revenue stood at $10000.0 in 2017, then declined by 10.0% to $9000.0 in 2018, then changed by 0.0% to $9000.0 in 2019.
- Business Quant data shows FBRX's Revenue at $9000.0 in Q4 2019, $9000.0 in Q3 2019, and $9000.0 in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Forte Biosciences | 1.58 Bn | 1.23 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 9,000.00 |
| Sep 30, 2019 | 9,000.00 |
| Jun 30, 2019 | 9,000.00 |
| Mar 31, 2019 | 9,000.00 |
| Dec 31, 2018 | 9,000.00 |
| Sep 30, 2018 | 18.01 Mn |
| Jun 30, 2018 | 9,000.00 |
| Mar 31, 2018 | 9,000.00 |
| Dec 31, 2017 | 10,000.00 |
| Sep 30, 2017 | 10,000.00 |
| Jun 30, 2017 | 10,000.00 |